227 related articles for article (PubMed ID: 36817433)
1. Different cytokine and chemokine profiles in hospitalized patients with COVID-19 during the first and second outbreaks from Argentina show no association with clinical comorbidities.
Almada L; Angiolini SC; Dho ND; Dutto J; Gazzoni Y; Manzone-Rodríguez C; Marín C; Ponce NE; Arroyo DS; Quiróz JN; Iribarren P; Cerbán FM; Morón G; Amezcua Vesely MC; Cervi L; Chiapello LS; Fozzatti L; Icely PA; Maccioni M; Montes CL; Motrán CC; Rodríguez-Galán MC; Stempin CC; Viano ME; Mena C; Bertone M; Abiega CD; Escudero D; Kahn A; Caeiro JP; Maletto BA; Acosta Rodríguez EV; Gruppi A; Sotomayor CE
Front Immunol; 2023; 14():1111797. PubMed ID: 36817433
[TBL] [Abstract][Full Text] [Related]
2. The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections.
Hsu RJ; Yu WC; Peng GR; Ye CH; Hu S; Chong PCT; Yap KY; Lee JYC; Lin WC; Yu SH
Front Immunol; 2022; 13():832394. PubMed ID: 35464491
[TBL] [Abstract][Full Text] [Related]
3. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
Front Immunol; 2021; 12():700921. PubMed ID: 34539631
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 and Sepsis.
Koçak Tufan Z; Kayaaslan B; Mer M
Turk J Med Sci; 2021 Dec; 51(SI-1):3301-3311. PubMed ID: 34590796
[TBL] [Abstract][Full Text] [Related]
5. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
[TBL] [Abstract][Full Text] [Related]
6. Association between inflammatory cytokines/chemokines, clinical laboratory parameters, disease severity and in-hospital mortality in critical and mild COVID-19 patients without comorbidities or immune-mediated diseases.
Hamza M; Alhujaily M; Alosaimi B; El Bakkouri K; AlDughaim MS; Alonazi M; Alanazi MA; Abbass B; Alshehri A; Al-Shouli ST; Alturaiki W; Awadalla M
J Immunoassay Immunochem; 2023 Jan; 44(1):13-30. PubMed ID: 35915975
[TBL] [Abstract][Full Text] [Related]
7. The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved.
Coperchini F; Chiovato L; Ricci G; Croce L; Magri F; Rotondi M
Cytokine Growth Factor Rev; 2021 Apr; 58():82-91. PubMed ID: 33573850
[TBL] [Abstract][Full Text] [Related]
8. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
9. Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions.
Jafarzadeh A; Chauhan P; Saha B; Jafarzadeh S; Nemati M
Life Sci; 2020 Sep; 257():118102. PubMed ID: 32687918
[TBL] [Abstract][Full Text] [Related]
10. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
[TBL] [Abstract][Full Text] [Related]
11. Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection.
Bozorgmehr N; Mashhouri S; Perez Rosero E; Xu L; Shahbaz S; Sligl W; Osman M; Kutsogiannis DJ; MacIntyre E; O'Neil CR; Elahi S
mBio; 2021 May; 12(3):. PubMed ID: 33947753
[TBL] [Abstract][Full Text] [Related]
12. Cytokines and Chemokines in SARS-CoV-2 Infections-Therapeutic Strategies Targeting Cytokine Storm.
Pum A; Ennemoser M; Adage T; Kungl AJ
Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33445810
[TBL] [Abstract][Full Text] [Related]
13. The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of "inflame-aging".
Meftahi GH; Jangravi Z; Sahraei H; Bahari Z
Inflamm Res; 2020 Sep; 69(9):825-839. PubMed ID: 32529477
[TBL] [Abstract][Full Text] [Related]
14. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
Panigrahy D; Gilligan MM; Huang S; Gartung A; Cortés-Puch I; Sime PJ; Phipps RP; Serhan CN; Hammock BD
Cancer Metastasis Rev; 2020 Jun; 39(2):337-340. PubMed ID: 32385712
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
Azar MM; Shin JJ; Kang I; Landry M
Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 in Kidney Transplant Recipients: A Multicenter Experience from the First Two Waves of Pandemic.
Demir E; Ucar ZA; Dheir H; Danis R; Yelken B; Uyar M; Parmaksiz E; Artan AS; Sinangil A; Merhametsiz O; Yadigar S; Dirim AB; Akin B; Garayeva N; Safak S; Turkmen A
BMC Nephrol; 2022 May; 23(1):183. PubMed ID: 35550025
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6, CXCL10 and Infiltrating Macrophages in COVID-19-Related Cytokine Storm: Not One for All But All for One!
Coperchini F; Chiovato L; Rotondi M
Front Immunol; 2021; 12():668507. PubMed ID: 33981314
[TBL] [Abstract][Full Text] [Related]
18. International Changes in COVID-19 Clinical Trajectories Across 315 Hospitals and 6 Countries: Retrospective Cohort Study.
Weber GM; Zhang HG; L'Yi S; Bonzel CL; Hong C; Avillach P; Gutiérrez-Sacristán A; Palmer NP; Tan ALM; Wang X; Yuan W; Gehlenborg N; Alloni A; Amendola DF; Bellasi A; Bellazzi R; Beraghi M; Bucalo M; Chiovato L; Cho K; Dagliati A; Estiri H; Follett RW; García Barrio N; Hanauer DA; Henderson DW; Ho YL; Holmes JH; Hutch MR; Kavuluru R; Kirchoff K; Klann JG; Krishnamurthy AK; Le TT; Liu M; Loh NHW; Lozano-Zahonero S; Luo Y; Maidlow S; Makoudjou A; Malovini A; Martins MR; Moal B; Morris M; Mowery DL; Murphy SN; Neuraz A; Ngiam KY; Okoshi MP; Omenn GS; Patel LP; Pedrera Jiménez M; Prudente RA; Samayamuthu MJ; Sanz Vidorreta FJ; Schriver ER; Schubert P; Serrano Balazote P; Tan BW; Tanni SE; Tibollo V; Visweswaran S; Wagholikar KB; Xia Z; Zöller D; ; Kohane IS; Cai T; South AM; Brat GA
J Med Internet Res; 2021 Oct; 23(10):e31400. PubMed ID: 34533459
[TBL] [Abstract][Full Text] [Related]
19. [Comparative analysis of clinical characteristics, evolution and mortality of hospitalized patients with COVID-19 during the first and second wave of the pandemic (ECCOVID Study)].
Córdova E; Mykietiuk A; De Vedia L; Bacelar B; Cáceres MF; Nemirovsky C; Contreras R; Alzogaray MF; Nannini E; Consalvo MF; Soler Puy L; Scapellato PG; Barcelona L; Golikow ML; Piñeiro MF; Miño HJ; Cabral M; Lamponi Tappata L; Lopardo G; Sued O; Stryjewski ME;
Medicina (B Aires); 2023; 83(4):551-557. PubMed ID: 37582129
[TBL] [Abstract][Full Text] [Related]
20. Immune Profiling of COVID-19 in Correlation with SARS and MERS.
Khalil BA; Shakartalla SB; Goel S; Madkhana B; Halwani R; Maghazachi AA; AlSafar H; Al-Omari B; Al Bataineh MT
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
